Interesting. This smarmy article is from 2015. Thanks for pointing that out.
It obviously was not a hit piece written regarding the current presidential race.
Thanks for pointing out the date.
Thank you.
It was difficult to reflect all the information in an concise manner because so many companies were started and had their names changed, were spun off and went broke. I posted multiple articles covering the years of the companies’ history.
2015 Axovant Sciences was formed and stock price doubled on the promise of a drug sold to the new company by GlaxoSmithKline. People became suspicious about the valuation for an unproven drug in a 10 person company with relatives, and the stock price tanked.
April 10, 2018 Biotech vet David Hung wipes Axovant from his work history By Damian Garde
Axovant failed the key phase 3 MINDSET trial for its lead drug intepirdine in treating Alzheimer’s disease. Following this, a second trial failure for nelotanserin in treating dementia due to Lewy Body Disease resulted in the stock falling to below $1 and the CEO Hung (former CEO of Medivation) quitting.
2019 Axovant: Axovant Gene Therapies (AXGT) is the new name for former Axovant Sciences An Interesting Turnaround Story With A Promising Pipeline Feb. 21, 2019. This company was rebranded a year later...
Nov 10, 2020 ‘We’re not a vant’: Axovant seeks to forget the past as the company rebrands to Sio Gene Therapies Max
In April 2023 the shareholders of Sio Gene Therapies voted to liquidate and dissolve the company.